PKM2 Promotes Breast Cancer Progression by Regulating Epithelial Mesenchymal Transition
Breast cancer is the leading cause of females characterized by high invasive potential. It is necessary to explore the underlying mechanism of breast cancer metastases and to find specific therapeutic targets. PKM2 is considered a new biomarker of cancer with upregulated expression in tumor tissue....
Saved in:
Main Authors: | Hui Xiao, Longxiao Zhang, Yuan Chen, Chengjun Zhou, Xiao Wang, Dehai Wang, Zhenzhong Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Analytical Cellular Pathology |
Online Access: | http://dx.doi.org/10.1155/2020/8396023 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SHP2 promotes the epithelial-mesenchymal transition in triple negative breast cancer cells by regulating β-catenin
by: Shihan Qian, et al.
Published: (2025-01-01) -
MYH9 promotes malignant progression of glioma cells through regulating β-catenin stability via epithelial-mesenchymal transition signaling pathway
by: Zigui Chen, et al.
Published: (2025-02-01) -
Expression of Angiogenesis Regulatory Proteins and Epithelial-Mesenchymal Transition Factors in Platelets of the Breast Cancer Patients
by: Hui Han, et al.
Published: (2014-01-01) -
The microRNA-200 Family Regulates Epithelial to Mesenchymal Transition
by: Emily L. Paterson, et al.
Published: (2008-01-01) -
The RNA M5C methyltransferase NSUN2 promotes progression of hepatocellular carcinoma by enhancing PKM2-mediated glycolysis
by: Qin Qi, et al.
Published: (2025-02-01)